BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Thermo Fisher's $76 million investment expands cell culture media production

To meet increasing global demand for cell culture media used in the manufacturing of new vaccines and biologics, Thermo Fisher Scientific has expanded its ...

August 04, 2022 | News

Agilent Acquires Polymer Standards Service, Broadening Offerings for GPC/SEC Polymer Analysis

PSS specializes in hardware and software solutions used in defining the makeup and creation of molecular structures. The company provides complete solution...

August 03, 2022 | News

Sustainable Manufacturing Practices: The Key to Mitigating Antimicrobial Resistance

The workshop program included training on the importance of sustainability in manufacturing practices of antibiotics, as well as a presentation of th...

July 27, 2022 | News

CSafe Global Continues Investment in Cell and Gene Therapy Solutions with Addition of New Portfolio President

CSafe Global, the innovation leader in temperature-controlled shipping solutions for the transport of life-enhancing pharmaceuticals, announced today...

July 26, 2022 | News

Polpharma Biologics Announces FDA File Acceptance for Review of Natalizumab, First Proposed Biosimilar to Tysabri®

The application is for an intravenous (IV) route of administration, with the same dosing regimen, presentation and indication as the reference medicine, Ty...

July 26, 2022 | News

Liminal BioSciences Announces Discontinuation of Fezagepras Development

The decision to discontinue the development of fezagepras is based on results from the Phase 1a single ascending dose ("SAD") clinical trial, which indicat...

July 22, 2022 | News

Navigo Proteins Successfully Develops Affinity Resin Against Ferritin for Blood Fraction Processing

(“Navigo”), a premier protein engineering company and developer of affinity ligands for custom chromatography solutions, today announces succes...

July 21, 2022 | News

Brii Bio Announces Strategic Partnership with China Resources Pharmaceutical Commercial Group

The partnership will accelerate stockpiling, channel distribution and hospital access for the amubarvimab/romlusevimab combination in China The ...

July 20, 2022 | News

Sobi to license loncastuximab tesirine from ADC Therapeutics

Sobi® announced an exclusive license agreement with ADC Therapeutics SA to develop and commercialise loncastuximab tesirine for use in haematology and ...

July 11, 2022 | News

WuXi XDC and AbTis Sign Memorandum of Understanding for Development and Manufacturing of Antibody Drug Conjugates

Under the partnership, AbTis will have access to WuXi XDC's integrated services for linker and payload manufacturing, ADC conjugation process developm...

July 08, 2022 | News

Enosi Therapeutics Partners with Danuo Science Group to Accelerate Multiple Therapeutic Programs

Enosi Therapeutics, a Delaware Corporation, focused on providing industry-leading therapeutics for cancer and autoimmune diseases, has announced a partners...

July 06, 2022 | News

AI Drives Data Insights for Doctors and their Patients

Dr. Lina Basel-Salmon has been treating rare disease patients at Schneider Children’s Medical Center of Israel and Beilinson Hospital at th...

July 04, 2022 | News

Twist Bioscience and Ildong Pharmaceutical Enter into a Collaboration to Enhance Antibody Discovery for Applications in Immuno-oncology

“This collaboration with Twist moves us closer to our vision of becoming a fully global healthcare company while also continuing to drive novel thera...

July 01, 2022 | News

BGI Group Continues To Lead In Life Sciences 22 Years After The Human Genome Project

BGI was formed to be a part of the HGP, contributing to the sequencing of genes and working alongside scientists from six countries. Twenty-two years ago t...

June 28, 2022 | News

Stay Connected